PFBT
SCMP

Parkside Financial Bank & Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Parkside Financial Bank & Trust’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-35
Closed -$1K – 1598
2017
Q4 		$1K Sell
35
-2
-5% -$25 ﹤0.01% 1331
2017
Q3 		$0 Hold
37
– – ﹤0.01% 1623
2017
Q2 		$0 Buy
37
+14
+61% +$143 ﹤0.01% 1643
2017
Q1 		$0 Buy
+23
New +$267 ﹤0.01% 1614

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Parkside Financial Bank & Trust's SCMP Position: Q1 2018 in Review

Parkside Financial Bank & Trust sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 35 shares — an estimated $1K sold.

Parkside Financial Bank & Trust first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $1K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Parkside Financial Bank & Trust reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 35 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1K.
  • Parkside Financial Bank & Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Sucampo Pharmaceuticals, Inc. position peaked at $1K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2018, filed 2 May 2018.